Product image of Panzyga (Human Normal Immunoglobulin) supplied by GNH India

Panzyga

Active Ingredient:
Human Normal Immunoglobulin
Origin:
EU

Panzyga (Human Normal Immunoglobulin)

Human normal immunoglobulin, the active ingredient in Panzyga, is an Immunoglobulin (IVIG) presented as a solution for injection for intravenous use. It provides passive immunity and is used in patients with primary or secondary immunodeficiency diseases and immune thrombocytopenic purpura. GNH India supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH India supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Octapharma Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Panzyga is used in immunology to replace deficient antibodies and modulate immune responses in several conditions.

  • Primary immunodeficiency diseases: helps restore normal IgG levels and reduces infection frequency.
  • Secondary immunodeficiency: supports immune function when antibody production is compromised.
  • Immune thrombocytopenic purpura: contributes to platelet count stabilization by immune modulation.

How It Works

  • Panzyga supplies pooled human IgG antibodies that bind to a broad range of antigens, providing passive immunity. The infused IgG interacts with Fc receptors on immune cells, modulating complement activation, cytokine release and antibody‑dependent cellular cytotoxicity, thereby restoring immune balance and reducing auto‑immune activity.

Side Effects

Adverse reactions to Panzyga can vary from mild to severe and are monitored during and after infusion.

Common Side Effects

  • Headache
  • Fever
  • Chills
  • Nausea
  • Fatigue
  • Myalgia

Serious or Rare Side Effects

  • Anaphylaxis
  • Thromboembolic events
  • Acute renal failure
  • Hemolytic anemia
  • Severe aseptic meningitis
  • Transfusion‑related acute lung injury (TRALI)

Precautions & Warnings

Before initiating therapy with Panzyga, clinicians should consider several safety aspects.

  • Renal function assessment: evaluate baseline kidney function and monitor during treatment.
  • Thrombotic risk evaluation: assess patient history for clotting disorders.
  • Infusion rate management: start with a slow rate and adjust based on tolerance.
  • Pre‑medication: consider antihistamines or analgesics to reduce infusion reactions.
  • Contraindications: avoid use in patients with known severe IgA deficiency with anti‑IgA antibodies.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Panzyga may interact with other medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid)

  • Live vaccines: concurrent administration can reduce vaccine efficacy and increase risk.

Moderate Interactions (Monitor Closely)

  • Corticosteroids: may enhance immunosuppressive effects, requiring dose adjustments.
  • Anticoagulants: increased risk of bleeding; monitor coagulation parameters.
  • Diuretics: may affect renal handling of fluids; watch for volume overload.
  • ACE inhibitors: potential for additive renal effects; monitor kidney function.
  • Rituximab: combined immunosuppression may increase infection risk.

Frequently Asked Questions

Panzyga is an intravenous immunoglobulin product used to replace deficient antibodies in primary and secondary immunodeficiency diseases and to modulate immune activity in immune thrombocytopenic purpura, helping reduce infections and stabilize platelet counts.

The pooled IgG antibodies in Panzyga bind to a wide range of antigens, providing passive immunity. They interact with immune‑cell Fc receptors, modulating complement activation, cytokine release and auto‑antibody activity, which helps restore immune balance.

The prescribed dose of Panzyga is individualized by the treating physician based on the patient’s weight, IgG level, and clinical response. Dosing regimens are determined by the prescriber and adjusted as needed.

Safety data for Panzyg aare limited, and the pregnancy category is unknown. Clinicians must weigh potential benefits against risks and consider available safety information before use in pregnant or nursing patients.

To order, submit an enquiry on the Panzyga product page at gnhindia.com, providing the required quantity and institutional credentials. GNH India works with hospitals, pharmacies and procurement teams worldwide, then replies with pricing, availability, cold‑chain shipping details and import documentation.

Panzyga is comparable to other IVIGs in providing pooled IgG for immune replacement, but formulation differences such as stabilizers, concentration and infusion tolerability may vary. Clinicians choose based on patient‑specific factors, product availability and regulatory approvals.

Panzyga should be stored at 2‑8°C, protected from light, and must not be frozen or shaken. Before use, inspect the solution for particles or discoloration and allow it to reach room temperature if required for infusion.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Normal Immunoglobulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT